Clinical Trial Update: A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks [NA]

View source ↗

Summary

An ongoing randomized, three-arm trial compares vonaprazan 10 mg and 20 mg with esomeprazole 40 mg for healing LA Grade B or higher reflux esophagitis at 8 week…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Reflux Esophagitis

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Vonaprazan (vonaprazan)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: GERD | NA | Status: RECRUITING